All Rights Reserved. Forward ® 2019
EBD Group Inc., 3150 Pio Pico Drive, Suite 201, 92008 Carlsbad, CA

DOWNLOAD THE REPORT NOW

Alongside venture capital and public market investment, biopharmaceutical company alliances remain key sources of capital for advancing drug discovery and development efforts across the industry. 

In this report, review biopharma dealmaking from January 2017 to June 2018:   

  • 243 alliances with a disclosed potential deal value of >$50 million   

  • 52 biopharma company acquisitions with disclosed upfront payments that were worth nearly $184 billion in guaranteed payments   

GET THE FACTS BEFORE THE DEAL  

THE ULTIMATE BIOPHARMA DEALMAKERS REPORT FOR ALLIANCES AND M&As

LEARN MORE >>

Download the report to read more!